Virtual Medicinal Product (VMP) - Co-beneldopa 12.5mg/50mg dispersible tablets sugar free
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-beneldopa 12.5mg/50mg dispersible tablets sugar free | Start Date 01-09-2007 | End Date |
| Previous Name | Previous Name Co-beneldopa 12.5mg/50mg dispersible tablets | Start Date 01-09-2004 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Dispersible tablet
- Ontology Form/Route
- suspension.oral
- Free From
- Sugar-free
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- N04BA02
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 04090100 | Start Date 04-04-2022 | End Date |
| Previous BNF 04090100 | Start Date 22-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 39706911000001107 | 26-05-2021 | |
| 323110001 | 10-11-2002 | 25-05-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Benserazide hydrochloride | Based on Base Substance | Benserazide | 12.5 mg | |
| Levodopa | Based on Ingredient Substance | 50 mg |
Name
Benserazide hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Benserazide
Strength and UOM (Nmr)
12.5
Strength and UOM (Dmr)
Name
Levodopa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
Parent Products
-
VTMCo-beneldopa
-
VMP(Current) Co-beneldopa 12.5mg/50mg dispersible...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 100 tablet | 590 | Part VIIIA Category C |